Search News
| 5.46 Delayed Data As of Sep 21 |  -0.04 / -0.73%Today’s Change | 1.74 Today|||52-Week Range 6.99 | +203.33% Year-to-Date |
| Options Traders Expect Huge Moves in Geron (GERN) Stock Sep 13 / Zacks.com - Paid Partner Content |
| Previous close | 5.50 |
| Today’s open | 5.50 |
| Day’s range | 5.44 - 5.58 |
| Volume | 13,469,992 |
| Average volume (3 months) | 5,901,639 |
| Market cap | $1.0B |
| Earnings growth (last year) | +5.26% |
| Earnings growth (this year) | +161.11% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | -82.72% |
| P/E ratio | NM |
| Price/Sales | 269.11 |
| Price/Book | 8.41 |
| Today’s change | Today’s % change | |
|---|---|---|
| CHRSCoherus BioSciences ... | -0.40 | -2.45% |
| RYTMRhythm Pharmaceutica... | +1.01 | +3.25% |
| ADAPAdaptimmune Therapeu... | -0.26 | -2.17% |
| ZLABZai Lab Ltd | -0.36 | -1.84% |
| Next reporting date | November 8, 2018 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $1.1M |
| Annual profit (last year) | -$27.9M |
| Net profit margin | -2,621.22% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director John A. Scarlett |
Chief Financial Officer, Treasurer & Executive VP Olivia K. Bloom |
Corporate headquarters Menlo Park, California |
